Loomis, Sayles & Company’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.7K | Buy |
640
+76
| +13% | +$8.16K | ﹤0.01% | 591 |
|
|
2025
Q1 | $57K | Sell |
564
-305
| -35% | -$30.8K | ﹤0.01% | 611 |
|
|
2024
Q4 | $78K | Sell |
869
-90
| -9% | -$8.08K | ﹤0.01% | 589 |
|
|
2024
Q3 | $80K | Buy |
959
+17
| +2% | +$1.42K | ﹤0.01% | 576 |
|
|
2024
Q2 | $73K | Buy |
942
+19
| +2% | +$1.47K | ﹤0.01% | 585 |
|
|
2024
Q1 | $63K | Sell |
923
-20
| -2% | -$1.37K | ﹤0.01% | 594 |
|
|
2023
Q4 | $55K | Buy |
943
+59
| +7% | +$3.44K | ﹤0.01% | 597 |
|
|
2023
Q3 | $47K | Buy |
884
+99
| +13% | +$5.26K | ﹤0.01% | 612 |
|
|
2023
Q2 | $42K | Hold |
785
| – | – | ﹤0.01% | 638 |
|
|
2023
Q1 | $39K | Buy |
+785
| New | +$39K | ﹤0.01% | 654 |
|
|
2022
Q3 | – | Sell |
-527
| Closed | -$20K | – | 957 |
|
|
2022
Q2 | $20K | Buy |
527
+211
| +67% | +$8.01K | ﹤0.01% | 598 |
|
|
2022
Q1 | $14K | Sell |
316
-162
| -34% | -$7.18K | ﹤0.01% | 661 |
|
|
2021
Q4 | $20K | Sell |
478
-60
| -11% | -$2.51K | ﹤0.01% | 683 |
|
|
2021
Q3 | $23K | Buy |
538
+2
| +0.4% | +$86 | ﹤0.01% | 669 |
|
|
2021
Q2 | $23K | Buy |
536
+24
| +5% | +$1.03K | ﹤0.01% | 654 |
|
|
2021
Q1 | $20K | Sell |
512
-177
| -26% | -$6.91K | ﹤0.01% | 655 |
|
|
2020
Q4 | $25K | Sell |
689
-57
| -8% | -$2.07K | ﹤0.01% | 606 |
|
|
2020
Q3 | $29K | Buy |
+746
| New | +$29K | ﹤0.01% | 583 |
|
|
2013
Q4 | – | Sell |
-1,456,735
| Closed | -$17.1M | – | 755 |
|
|
2013
Q3 | $17.1M | Buy |
+1,456,735
| New | +$17.1M | 0.06% | 381 |
|